SIM
LXRX icon

Spark Investment Management’s Lexicon Pharmaceuticals LXRX Stock Holding History

Spark Investment Management’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-143,248
Closed -$279K – 189
2020
Q1 		$279K Sell
143,248
-219,852
-61% -$654K 0.15% 194
2019
Q4 		$1.51M Buy
+363,100
New +$1.4M 0.18% 170
2017
Q1 		– Sell
-35,020
Closed -$484K – 857
2016
Q4 		$484K Buy
+35,020
New +$562K 0.04% 495
2015
Q1 		– Sell
-11,443
Closed -$72K – 737
2014
Q4 		$72K Buy
+11,443
New +$92.2K 0.01% 614

Other funds holding LXRX

AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
UL
Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Spark Investment Management's LXRX Position: Q2 2020 in Review

Spark Investment Management sold out of Lexicon Pharmaceuticals (LXRX) in Q2 2020, closing a stake of 143,248 shares — an estimated $279K sold.

Spark Investment Management first reported a position in LXRX in Q4 2014 and held it in 4 quarters. The position peaked at $1.51M in Q4 2019. 108 funds tracked by Wall St. Rank hold LXRX as of Q2 2020.

  • Spark Investment Management reported no remaining Lexicon Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
  • Spark Investment Management sold 143,248 Lexicon Pharmaceuticals shares in Q2 2020, an estimated $279K.
  • Spark Investment Management first reported a position in Lexicon Pharmaceuticals in Q4 2014 and held it in 4 quarters.
  • Spark Investment Management's Lexicon Pharmaceuticals position peaked at $1.51M in Q4 2019.
  • 108 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q2 2020.

Based on Spark Investment Management's 13F filing for Q2 2020, filed 12 Aug 2020.